Economic crisis, health and

Size: px
Start display at page:

Download "Economic crisis, health and"

Transcription

1 Economic crisis, health and health systems Marina Karanikolos response in Greece Reseach Fellow ECOHOST, LSHTM

2 Health System in Greece Health System Review (2010) precrisis NHS (ESY) coexists with SHI model and private sector Private expenditure accounts for 40% of THE (3rd largest in EU) Serious inefficiencies, including: High degree of centralization; Lack of planning and coordinantion

3 Memorandum of Understanding (March 2012) Troika and MoU for Greece: PHE at 6% of GDP 2 bln savings in pharmaceuticals between 2010 and 2012 (through pricing mechanisms and prescribing monitoring) 25% decrease in expenditure for joint purchase of medical services and goods (by end 2011)

4 Memorandum of Understanding (March 2012) Some things happened or underway: Introduction of DGRs Some progress in eprescribing and monitoring Pharmaceuticals expenditure decreased... but...

5 Pharmaceutical policies Lowering of drug prices pushed wholesalers to sell abroad to increase profits SHI fund owes pharmacists ( 400 million) who are unable to pay suppliers 500 commonly used drugs are in short supply. Among them, there are drugs for hypertension, gastroenterological disorders, cancer, kidney diseases, and pain killers. Karamanoli E. (2012), the Lancet Vol 379:9813, p 302

6 Pharmaceutical policies General moratorium As a temporary measure to protect the public health and to avoid shortages of drugs associated with the entry into force of the new prices on pharmaceuticals, EOF makes recommendations to all stakeholders for general temporary suspension of exports and intracommunity

7 Pharmaceutical policies

8 Health services and access 40% cuts in hospital budgets Shortage of staff and medical supplies 24% rise in admissions to public hospitals; 2530% fall in admissions to private hospitals

9 Health outcomes 15% increase in bad selfreported health ( ) Increase in infant mortality and stillbirths in 2010 and 2011 (Eurostat; Vlachadis & Kornarou, BMJ 2013;346:f1061 (Kentikelenis A, et al. 2011) Increase in heart attacks since 2008 (Makaris, ACC European Observatory on Health Systems and Policies Conference 10/03/2013)

10 Mental health 120% increase in MH service use over 3 years (Anagnostopoulos & Soumaki, 2013) 2.5 times increase in major depression between 2008 and 2011 (Economou et al, 2012)

11 Mental health State funding for MH decreased by 20% in 2011 and further 55% in Large number of MH service provides (community centres, psychosocial rehabilitation units, highly specialised establishments) have suspended operation

12 Infectious diseases Crisis undermines health system's capacity for infections prevention and control Danis et al., 2013)

13 Infectious diseases HIV outbreak coincides with budgetary cuts in the health system (especially the field of drug treatment and harm reduction), the deteriorating socio economic environment of the Athens city centre, and changes in injecting behaviours among IDUs. HIV outbreak among injecting drug users in Greece An updated report to the EMCDDA 2012

14 Infectious diseases NGOs are filling in the gaps in health service provision:

15 The weather is better than in some other countries... Follow us on Thank you!

HIV outbreaks among PWID in Europe linking economic, epidemiological and service provision data -

HIV outbreaks among PWID in Europe linking economic, epidemiological and service provision data - HIV outbreaks among PWID in Europe linking economic, epidemiological and service provision data - EMCDDA annual expert meeting on drug-related deaths and drug-related infectious diseases 18/10 /2013 -

More information

Recent trends in drug problems and service provision in Greece

Recent trends in drug problems and service provision in Greece Recent trends in drug problems and service provision in Greece Anastasios Fotiou Epidemiology Unit The Greek Reitox focal point of the EMCDDA at the Understanding the dynamics, nature and scale of drug

More information

Post-2015: Innovative Financing of HIV/AIDS. Travis Mitchell Economic Affairs Division

Post-2015: Innovative Financing of HIV/AIDS. Travis Mitchell Economic Affairs Division Post-2015: Innovative Financing of HIV/AIDS Travis Mitchell Economic Affairs Division High Burden (HIV/AIDS) Low Income countries will remain dependent on external funding for decades, creating major financial

More information

Clive Richardson Panteion University of Social & Political Sciences, Athens & Greek Reitox Focal Point

Clive Richardson Panteion University of Social & Political Sciences, Athens & Greek Reitox Focal Point National income inequality and declining GDP growth rates are associated with increases in HIV diagnoses among people who inject drugs in Europe: A panel data analysis Clive Richardson Panteion University

More information

Report. Uganda Pharmaceutical Sector Scan JUNE 2010

Report. Uganda Pharmaceutical Sector Scan JUNE 2010 Report On the Uganda Pharmaceutical Sector Scan Part of Component 1 of MeTA Baseline Assessments JUNE 2010 Drafted by consultants: 1. Samuel Balyejjusa, B.Pharm., MPH 2. Paschal Mujasi, B.Pharm., MBA 3.

More information

Economic Recession and Health: the Case of Greece

Economic Recession and Health: the Case of Greece Economic Recession and Health: the Case of Greece Dr. Filippos Filippidis School of Public Health Imperial College London 1 Outline Background Economic recession in Greece Economic recession and health

More information

The epidemiology of HIV infection in Greece HIV/AIDS reporting system

The epidemiology of HIV infection in Greece HIV/AIDS reporting system HIV outbreak in IDUsin Greece Update on situation and responses Anastasios Fotiou, REITOX Focal Point-Greece Foteini Giannou, Office of HIV and STIs, Hellenic Centre for Disease Control and Prevention

More information

The impact of economic recession on drug users and drug treatment

The impact of economic recession on drug users and drug treatment The impact of economic recession on drug users and drug treatment Designing and implementing responsive drug policies under fiscal constraints: the case of Greece Meni Malliori Assoc. Prof. of Psychiatry

More information

The Home Office Proposals to schedule pregabalin and gabapentin under the Misuse of Drugs Regulations 2001 January 2018

The Home Office Proposals to schedule pregabalin and gabapentin under the Misuse of Drugs Regulations 2001 January 2018 The Home Office Proposals to schedule pregabalin and gabapentin under the Misuse of Drugs Regulations 2001 January 2018 Prepared by: Adam Osprey Policy & Development Pharmacist adam.osprey@cps.scot Who

More information

Botswana Advocacy paper on Resource Mobilisation for HIV and AIDS

Botswana Advocacy paper on Resource Mobilisation for HIV and AIDS Republic of Botswana Botswana Advocacy paper on Resource Mobilisation for HIV and AIDS Page 1 June 2012 1.0 Background HIV and AIDS remains one of the critical human development challenges in Botswana.

More information

Prepared By Dr. Osama Refaat. International Consultant Population Communication Resource Person

Prepared By Dr. Osama Refaat. International Consultant Population Communication Resource Person Prepared By Dr. Osama Refaat International Consultant Population Communication Resource Person 1 Acknowledgement I would like to thank Dr. Joe Thomas, Dr. Nazrul Islam and all PPD family for their kind

More information

- Description, Objectives, Operational Framework

- Description, Objectives, Operational Framework 2 1. CNCD - Overview (significance, causes, burden) 2. CDAP - Description, Objectives, Operational Framework 3. Research Findings of Study on CDAP - Research Objectives and Methodology - Limitations and

More information

AUSTERITY, ECONOMIC CRISIS, AND THEIR PERSISTENT EFFECTS ON MENTAL HEALTH IN GREECE

AUSTERITY, ECONOMIC CRISIS, AND THEIR PERSISTENT EFFECTS ON MENTAL HEALTH IN GREECE Psihijat.dan./2016 /48/2 / 155-160/ 155 Opšti rad UDK 613.86(495) COBISS.SR-ID 237509644 AUSTERITY, ECONOMIC CRISIS, AND THEIR PERSISTENT EFFECTS ON MENTAL HEALTH IN GREECE Nikos Christodoulou 1, George

More information

5 $3 billion per disease

5 $3 billion per disease $3 billion per disease Chapter at a glance Our aim is to set a market size large enough to attract serious commercial investment from several pharmaceutical companies that see technological opportunites,

More information

Tunisia. Medicine prices, availability, affordability and price components. Medicine prices matter. Tunisia

Tunisia. Medicine prices, availability, affordability and price components. Medicine prices matter. Tunisia prices, availability, affordability and price components prices matter Rapidly rising costs of health care and high medicine prices are a growing concern worldwide, especially in developing and transitional

More information

What can the NHS do to reduce premature mortality? Professor Sir Mike Richards NHS Health Check National Learning Event April 2013

What can the NHS do to reduce premature mortality? Professor Sir Mike Richards NHS Health Check National Learning Event April 2013 What can the NHS do to reduce premature mortality? Professor Sir Mike Richards NHS Health Check National Learning Event April 2013 The role of the NHS in reducing premature mortality Overview The scale

More information

Pharmaceutical Pricing & Reimbursement Information. PPRI Project Co-ordination Sabine Vogler, Gesundheit Österreich GmbH

Pharmaceutical Pricing & Reimbursement Information. PPRI Project Co-ordination Sabine Vogler, Gesundheit Österreich GmbH PPRI - Comparative Analysis PPRI Project Co-ordination Sabine Vogler, Gesundheit Österreich GmbH PPRI Conference Vienna, 29 June 2007 PPRI Conference, Vienna, 29 June 2007 1 Comparative Analysis - Outline

More information

The Global Economic Crisis and HIV Prevention and Treatment Programmes: Vulnerabilities and Impact. Executive Summary TRINIDAD AND TOBAGO

The Global Economic Crisis and HIV Prevention and Treatment Programmes: Vulnerabilities and Impact. Executive Summary TRINIDAD AND TOBAGO The Global Economic Crisis and HIV Prevention and Treatment Programmes: Vulnerabilities and Impact Executive Summary TRINIDAD AND TOBAGO October 2009 ACKOWLEDGEMENT The executive summary The Global Economic

More information

increased efficiency. 27, 20

increased efficiency. 27, 20 Table S1. Summary of the evidence on the determinants of costs and efficiency in economies of scale (n=40) a. ECONOMETRIC STUDIES (n=9) Antiretroviral therapy (n=2) Scale was found to explain 48.4% of

More information

American Vaping Association

American Vaping Association Vaping.info American Vaping Association Gregory Conley, J.D., M.BA. President American Vaping Association Research Fellow Heartland Institute Member -- Gregory Conley Consulting, LLC Twitter: @GregTHR

More information

Identifying the Barriers for Access to Care and Treatment for Arterial Hypertension and Diabetes in Lima, Peru

Identifying the Barriers for Access to Care and Treatment for Arterial Hypertension and Diabetes in Lima, Peru Identifying the Barriers for Access to Care and Treatment for Arterial Hypertension and Diabetes in Lima, Peru Executive Summary María Kathia Cárdenas, Dulce Morán, David Beran & Jaime Miranda Identifying

More information

LAO PEOPLE S DEMOCRATIC REPUBLIC PEACE INDEPENDENCE DEMOCRACY UNITY PROSPERITY

LAO PEOPLE S DEMOCRATIC REPUBLIC PEACE INDEPENDENCE DEMOCRACY UNITY PROSPERITY LAO PEOPLE S DEMOCRATIC REPUBLIC PEACE INDEPENDENCE DEMOCRACY UNITY PROSPERITY President s Office No. 13/PO DECREE of the PRESIDENT of the LAO PEOPLE S DEMOCRATIC REPUBLIC On the Promulgation of the Law

More information

DEVELOPMENT. The European Union confronts HIV/AIDS, malaria and tuberculosis. A comprehensive strategy for the new millennium EUROPEAN COMMISSION

DEVELOPMENT. The European Union confronts HIV/AIDS, malaria and tuberculosis. A comprehensive strategy for the new millennium EUROPEAN COMMISSION DEVELOPMENT The European Union confronts HIV/AIDS, malaria and tuberculosis A comprehensive strategy for the new millennium EUROPEAN COMMISSION DE 121 FEB 2004 A global challenge Every minute, 11 people

More information

Financing the Response to AIDS in Low- and Middle- Income Countries: International Assistance from Donor Governments in 2011

Financing the Response to AIDS in Low- and Middle- Income Countries: International Assistance from Donor Governments in 2011 Financing the Response to AIDS in Low- and Middle- Income Countries: International Assistance from Donor Governments in 2011 Authors: Jennifer Kates (Kaiser Family Foundation), Adam Wexler (Kaiser Family

More information

Cote d Ivoire: Family Planning and HIV Prevention

Cote d Ivoire: Family Planning and HIV Prevention Cote d Ivoire: Family Planning and HIV Prevention Ex-post evaluation report OECD sector 13030 - Family planning BMZ project ID 1999 66 417 Project executing agency Consultant Ministry of Health/Agence

More information

Challenges and opportunities in heart failure treatment: Irish example

Challenges and opportunities in heart failure treatment: Irish example Challenges and opportunities in heart failure treatment: Irish example Joe Gallagher University College Dublin Ireland The Irish healthcare system Mixed public and private funding Primary healthcare is

More information

The National perspective Public Health England s vision, mission and priorities

The National perspective Public Health England s vision, mission and priorities The National perspective Public Health England s vision, mission and priorities Dr Ann Hoskins Director Children, Young People and Families Public Health England May 2013 Mission Public Health England

More information

Young onset dementia service Doncaster

Young onset dementia service Doncaster Young onset dementia service Doncaster RDaSH Older People s Mental Health Services Introduction The following procedures and protocols will govern the operational working and function of the Doncaster

More information

Kyrgyzstan. Medicine prices, availability, affordability & price components

Kyrgyzstan. Medicine prices, availability, affordability & price components Kyrgyzstan Medicine prices, availability, affordability & price components Medicine prices matter Rapidly rising costs of health care and high medicine prices are a growing concern worldwide, especially

More information

Implementation plan for the systems approach to suicide prevention in NSW

Implementation plan for the systems approach to suicide prevention in NSW Implementation plan for the systems approach to suicide prevention in NSW Summary paper October 2015 Putting health in mind IMPLEMENTATION PLAN FOR THE SYSTEMS APPROACH TO SUICIDE PREVENTION IN NSW Rationale

More information

Proof of Concept: NHS Wales Atlas of Variation for Cardiovascular Disease. Produced on behalf of NHS Wales and Welsh Government

Proof of Concept: NHS Wales Atlas of Variation for Cardiovascular Disease. Produced on behalf of NHS Wales and Welsh Government Proof of Concept: NHS Wales Atlas of Variation for Cardiovascular Disease Produced on behalf of NHS Wales and Welsh Government April 2018 Table of Contents Introduction... 3 Variation in health services...

More information

The alcohol market is in need of a thorough review

The alcohol market is in need of a thorough review Summary Alcohol, tobacco and gambling create costs for Swedish society in the form of production losses and extra expenditure for the public sector, for example. At the same time, these goods are valuable

More information

Hana Ross, PhD American Cancer Society and the International Tobacco Evidence Network (ITEN)

Hana Ross, PhD American Cancer Society and the International Tobacco Evidence Network (ITEN) The Costs of Smoking Hana Ross, PhD American Cancer Society and the International Tobacco Evidence Network (ITEN) Why Do We Study the Cost of Smoking? To assess the economic impact of smoking behavior

More information

New trends in harm reduction in Europe: progress made challenges ahead

New trends in harm reduction in Europe: progress made challenges ahead New trends in harm reduction in Europe: progress made challenges ahead Dagmar Hedrich, Alessandro Pirona, EMCDDA 2 nd European Harm Reduction Conference, 7-9 May 2014, Basel Session 4: Changes in harm

More information

Ex Post-Evaluation Brief ETHIOPIA: Family Planning and HIV Prevention I and II

Ex Post-Evaluation Brief ETHIOPIA: Family Planning and HIV Prevention I and II Ex Post-Evaluation Brief ETHIOPIA: Family Planning and HIV Prevention I and II Family Planning and HIV Prevention I and II Programme/Client 1998 65 163, 2002 66 197* Programme executing agency Programming

More information

State of provision of Hearing Aids in Europe

State of provision of Hearing Aids in Europe Creating a barrier-free Europe for all hard of hearing citizens State of provision of Hearing Aids in Europe 2018 Report 1 Executive Summary Dear Reader, We are pleased to share the report examining affordability

More information

2 nd Meeting on detecting and responding to outbreaks of HIV among PWID

2 nd Meeting on detecting and responding to outbreaks of HIV among PWID 2 nd Meeting on detecting and responding to outbreaks of HIV among PWID Update on country situation: AUSTRIA Lisbon, 12 th October 201 Epidemiological update 2 HIV notifications in PWID Number of HIV cases

More information

DECISION MAKING FOR NCDs IN KENYA. Dr. Francis Kimani Director of Medical Services Ministry of Medical Services, Government of Kenya

DECISION MAKING FOR NCDs IN KENYA. Dr. Francis Kimani Director of Medical Services Ministry of Medical Services, Government of Kenya DECISION MAKING FOR NCDs IN KENYA Dr. Francis Kimani Director of Medical Services Ministry of Medical Services, Government of Kenya AFRICA Kenya GEOGRAPHY OF KENYA ECONOMIC INDICATORS Population of about

More information

Evidence based assessment of the value of innovation: pricing solutions and prospects

Evidence based assessment of the value of innovation: pricing solutions and prospects Evidence based assessment of the value of innovation: pricing solutions and prospects Karl Claxton 7/11/2017 How much can we pay for innovation? Cost Price > P* 60,000 30,000 per QALY Cost-effectiveness

More information

Key Highlights continued

Key Highlights continued Financing the Response to AIDS in Low- and Middle- Income Countries: International Assistance from the G8, European Commission and Other Donor Governments in 2009 Authors: Jennifer Kates (Kaiser Family

More information

Representing Homeopaths in Europe

Representing Homeopaths in Europe The European Council for Classical Homeopathy School House, Market Place, Kenninghall, Norfolk NR16 2AH United Kingdom Telephone & Fax: (44) 1953 888163 http://www.homeopathy-ecch.org Email: ecch@homeopathy-ecch.org

More information

The evolution of the HIV/AIDS outbreak among IDUs in Romania

The evolution of the HIV/AIDS outbreak among IDUs in Romania The evolution of the HIV/AIDS outbreak among IDUs in Romania Romanian National Antidrug Agency Romanian National Focal Point on Drugs Andrei Botescu * Lisbon, 12 th October 2012 HIV outbreak among IDU

More information

HIV-1 Vaccine Development Clinical Trials and Public Health Benefits Chaiyos Kunanusont HIV/AIDS Adviser United Nations Population Fund

HIV-1 Vaccine Development Clinical Trials and Public Health Benefits Chaiyos Kunanusont HIV/AIDS Adviser United Nations Population Fund The 2 nd Advanced Vaccinology course (NVCO) DDC, Radisson Bangkok 15 17 June 2010 HIV-1 Vaccine Development Clinical Trials and Public Health Benefits Chaiyos Kunanusont HIV/AIDS Adviser United Nations

More information

The health economic landscape of cancer in Europe

The health economic landscape of cancer in Europe 1 Approval number The health economic landscape of cancer in Europe Bengt Jönsson, Professor Emeritus of Health Economics Stockholm School of Economics 2 Disclaimer This presentation was developed by Professor

More information

Position Paper on Good & Services Tax (GST) on Medicines Why All Medicines Should Be Accorded GST Zero- Rate Treatment in Malaysia

Position Paper on Good & Services Tax (GST) on Medicines Why All Medicines Should Be Accorded GST Zero- Rate Treatment in Malaysia Position Paper on Good & Services Tax (GST) on Medicines Why All Medicines Should Be Accorded GST Zero- Rate Treatment in Malaysia INTRODUCTION: Medicines are essential and critical goods for all Malaysian

More information

Drug Policy and the HIV Movement. SAULIUS CAPLINSKAS MD, PhD

Drug Policy and the HIV Movement. SAULIUS CAPLINSKAS MD, PhD Drug Policy and the HIV Movement SAULIUS CAPLINSKAS MD, PhD Director, Lithuanian AIDS Centre Assoc. Prof., Mykolas Romeris University 14th ECAD Mayors Conference Fighting Against Drugs - From Different

More information

Introduction. Principles

Introduction. Principles NHS Health Scotland s position statement on Electronic Nicotine Delivery Systems ENDS - e-cigarettes and other smoking simulator products 31 October 2014 Introduction NHS Health Scotland is the national

More information

Current levels and recent trends in health inequalities in the EU: Updates from the EU Report

Current levels and recent trends in health inequalities in the EU: Updates from the EU Report Current levels and recent trends in health inequalities in the EU: Updates from the EU Report Anne Scott London Health Observatory Expert Working Group on Social Determinants and Health Inequalities Luxembourg,

More information

Drug situation in Greece

Drug situation in Greece 16/6/217 INDICATIONS FOR DECLINE IN HCV AND HIV INCIDENCE AMONG PEOPLE WHO INJECT DRUGS IN ATHENS, GREECE Anastasios Fotiou Greek Reitox focal point at the Athens University Mental Health Research Institute

More information

Vertical integration of health and social care for older people living with frailty in the Netherlands

Vertical integration of health and social care for older people living with frailty in the Netherlands Vertical integration of health and social care for older people living with frailty in the Netherlands Dimitri Varsamis PhD Programme Manager, Acute Care Clinical Policy and Strategy Unit, Medical Directorate,

More information

Shanghai. China. Medicine prices, availability and affordability

Shanghai. China. Medicine prices, availability and affordability Shanghai China Medicine prices, availability and affordability Medicine prices matter Rapidly rising costs of health care and high medicine prices are a growing concern worldwide, especially in developing

More information

Authors: Jennifer Kates (Kaiser Family Foundation), Eric Lief (The Stimson Center), Carlos Avila (UNAIDS).

Authors: Jennifer Kates (Kaiser Family Foundation), Eric Lief (The Stimson Center), Carlos Avila (UNAIDS). Financing the response to AIDS in low- and middleincome countries: International assistance from the G8, European Commission and other donor Governments in 2008 Authors: Jennifer Kates (Kaiser Family Foundation),

More information

Health. goalglobal.org

Health. goalglobal.org Health goalglobal.org Health In recent years, unprecedented progress has been made in reducing maternal and child mortality, and in the fight against malnutrition and infectious diseases. The under-five

More information

Strategy Strategic delivery: Setting standards Increasing and informing choice. Details: Output: Demonstrating efficiency economy and value

Strategy Strategic delivery: Setting standards Increasing and informing choice. Details: Output: Demonstrating efficiency economy and value Strategy 2017-20 Strategic delivery: Setting standards Increasing and informing choice Demonstrating efficiency economy and value Details: Meeting Authority Agenda item 7 Paper number HFEA (11/05/2016)

More information

NATIONAL INSTITUTE FOR CLINICAL EXCELLENCE SCOPE. Dementia: the management of dementia, including the use of antipsychotic medication in older people

NATIONAL INSTITUTE FOR CLINICAL EXCELLENCE SCOPE. Dementia: the management of dementia, including the use of antipsychotic medication in older people NATIONAL INSTITUTE FOR CLINICAL EXCELLENCE 1 Guideline title SCOPE Dementia: the management of dementia, including the use of antipsychotic medication in older people 1.1 Short title Dementia 2 Background

More information

HEALTHCARE IN THE DEVELOPING WORLD - THE ROLE OF INTELLECTUAL PROPERTY. ODI: 12 February 2003

HEALTHCARE IN THE DEVELOPING WORLD - THE ROLE OF INTELLECTUAL PROPERTY. ODI: 12 February 2003 HEALTHCARE IN THE DEVELOPING WORLD - THE ROLE OF INTELLECTUAL PROPERTY ODI: 12 February 2003 KEY QUESTIONS What role does IP play in the development of new drugs and vaccines for the developing world?

More information

NATIONAL DRUG POLICY OF THE TRANSITIONAL GOVERNMENT OF ETHIOPIA

NATIONAL DRUG POLICY OF THE TRANSITIONAL GOVERNMENT OF ETHIOPIA NATIONAL DRUG POLICY OF THE TRANSITIONAL GOVERNMENT OF ETHIOPIA Nov. 1993 NATIONAL DRUG POLICY OF THE TRANSITIONAL GOVERNMENT OF ETHIOPIA 5. Introduction Based on economic development

More information

EMCDDA-update HIV/HCV among people who inject drugs: situation and response

EMCDDA-update HIV/HCV among people who inject drugs: situation and response EMCDDA-update HIV/HCV among people who inject drugs: situation and response Dagmar Hedrich EU Think Tank HIV/AIDS: 24-25 November 2015, Luxembourg Latest European overview Multi-indicator based analysis

More information

BRIEFING ON WHY AND HOW TO ADDRESS OVERDOSE IN GLOBAL FUND PROPOSALS

BRIEFING ON WHY AND HOW TO ADDRESS OVERDOSE IN GLOBAL FUND PROPOSALS BRIEFING ON WHY AND HOW TO ADDRESS OVERDOSE IN GLOBAL FUND PROPOSALS For people who inject heroin and other opioids, overdose is an urgent issue. The Global Fund to Fight AIDS, Tuberculosis and Malaria

More information

Impact of health behaviours and health interventions on demand for and cost of NHS services in the North of Scotland (including Tayside)

Impact of health behaviours and health interventions on demand for and cost of NHS services in the North of Scotland (including Tayside) Impact of health behaviours and health interventions on demand for and cost of NHS services in the North of Scotland (including Tayside) Note: This paper is based on a report originally produced by Dr

More information

KEY QUESTIONS What outcome do you want to achieve for mental health in Scotland? What specific steps can be taken to achieve change?

KEY QUESTIONS What outcome do you want to achieve for mental health in Scotland? What specific steps can be taken to achieve change? SCOTTISH GOVERNMENT: NEXT MENTAL HEALTH STRATEGY Background The current Mental Health Strategy covers the period 2012 to 2015. We are working on the development of the next strategy for Mental Health.

More information

New EU Health Programme: funding mechanisms for civil society working on HIV and related areas

New EU Health Programme: funding mechanisms for civil society working on HIV and related areas New EU Health Programme: funding mechanisms for civil society working on HIV and related areas Cinthia Menel Lemos Think Tank meeting Luxembourg, 10 December 2013 Executive Agency for Health and Consumers

More information

UN Panel Discussion Millennium Development Goals. Ajay Singh Senior Director Dr Reddy s Laboratories 07 July 2010

UN Panel Discussion Millennium Development Goals. Ajay Singh Senior Director Dr Reddy s Laboratories 07 July 2010 UN Panel Discussion Millennium Development Goals Ajay Singh Senior Director Dr Reddy s Laboratories 07 July 2010 1 A role for everyone. North Large branded companies Strong engine of innovation Almost

More information

Executive Board of the United Nations Development Programme and of the United Nations Population Fund

Executive Board of the United Nations Development Programme and of the United Nations Population Fund United Nations DP/FPA/CPD/ALB/2 Executive Board of the United Nations Development Programme and of the United Nations Population Fund Distr.: General 11 October 2005 Original: English UNITED NATIONS POPULATION

More information

Measures to prepare for Health Pandemics Liberia

Measures to prepare for Health Pandemics Liberia Measures to prepare for Health Pandemics Liberia Presented by: MOH/MFDP Outline 1. General overview of health sector 2. Ebola in Liberia 3. Measures to prepare for pandemics: Building a resilient health

More information

Resource impact report: Sofosbuvir velpatasvir for treating chronic hepatitis C TA430

Resource impact report: Sofosbuvir velpatasvir for treating chronic hepatitis C TA430 Putting NICE guidance into practice Resource impact report: Sofosbuvir velpatasvir for treating chronic hepatitis C TA430 Published: January 2017 Summary Sofosbuvir velpatasvir is recommended as an option

More information

WHO HHS Workshop on Business Modeling for Sustainable Influenza Vaccine Manufacturing

WHO HHS Workshop on Business Modeling for Sustainable Influenza Vaccine Manufacturing WHO HHS Workshop on Business Modeling for Sustainable Influenza Vaccine Manufacturing Washington, DC January 14th 16th, 2013 Session 4: Attracting Investments and Generating Revenue Theory, Practice and

More information

HEPATITIS ELIMINATION IN SUB-SAHARAN AFRICA: WHAT WILL IT TAKE?

HEPATITIS ELIMINATION IN SUB-SAHARAN AFRICA: WHAT WILL IT TAKE? HEPATITIS ELIMINATION IN SUB-SAHARAN AFRICA: WHAT WILL IT TAKE? Ganiyat Kikelomo OYELEKE FMCP Hepatologist & Gastroenterologist Lagos University Teaching Hospital, Nigeria. INTEREST 2018, KIGALI CONFERENCE

More information

Introduction CHAPTER ONE

Introduction CHAPTER ONE CHAPTER ONE Introduction As we approach the fourth decade of the HIV/AIDS epidemic, it is becoming increasingly clear that HIV/AIDS has diverse implications and affects virtually all aspects of society.

More information

Ready, Willing, and Able? Challenges Faced by Countries Losing Global Fund Support

Ready, Willing, and Able? Challenges Faced by Countries Losing Global Fund Support D r a f t D i s c u s s i o n P a p e r Ready, Willing, and Able? Challenges Faced by Countries Losing Global Fund Support Updated: July 30, 2015 224 WEST 57 th St., New York, NY 10019 T EL 1-212-548-0600

More information

Chad: Family Planning / HIV Prevention I to III 2.) ) ) GFA Medica 3.) GFA Medica 2.) Q

Chad: Family Planning / HIV Prevention I to III 2.) ) ) GFA Medica 3.) GFA Medica 2.) Q Ex-post Evaluation Report OECD sector Chad: Family Planning / HIV Prevention I to III 1.) 13030/Family planning BMZ project ID 1.) 1994 664 75 Project executing agency Consultant 1.) PSI Year of ex post

More information

SPECIAL EVENT ON PHILANTHROPY AND THE GLOBAL PUBLIC HEALTH AGENDA. 23 February 2009, United Nations, New York Conference Room 2, 3:00 p.m. 6:00 p.m.

SPECIAL EVENT ON PHILANTHROPY AND THE GLOBAL PUBLIC HEALTH AGENDA. 23 February 2009, United Nations, New York Conference Room 2, 3:00 p.m. 6:00 p.m. SPECIAL EVENT ON PHILANTHROPY AND THE GLOBAL PUBLIC HEALTH AGENDA 23 February 2009, United Nations, New York Conference Room 2, 3:00 p.m. 6:00 p.m. ISSUES NOTE Improving the Health Outcomes of Women and

More information

HOW TO ARTICULATE THE PROBLEM Conducting a Situational Analysis for a Drug Abuse Prevention Programme P R O C C E R

HOW TO ARTICULATE THE PROBLEM Conducting a Situational Analysis for a Drug Abuse Prevention Programme P R O C C E R HOW TO ARTICULATE THE PROBLEM Conducting a Situational Analysis for a Drug Abuse Prevention Programme Do We Really Know What We Know Do you have a drug problem in your community? # of Users # of Related

More information

Most recent data, analyses and feed-back from the 2016 DRID national updates

Most recent data, analyses and feed-back from the 2016 DRID national updates Most recent data, analyses and feed-back from the 216 DRID national updates Eleni Kalamara, Dagmar Hedrich, Linda Montanari, Isabelle Giraudon 15-16 June 217, Lisbon DRID/TDI annual expert meeting DRID

More information

Parallel trade: are industry concerns real or imagined?

Parallel trade: are industry concerns real or imagined? Parallel trade: are industry concerns real or imagined? Steve Chaplin MSc, MRPharmS The parallel trade in medicines is claimed to save money for the NHS, but results in lost profits for the pharmaceutical

More information

The new PH landscape Opportunities for collaboration

The new PH landscape Opportunities for collaboration The new PH landscape Opportunities for collaboration Dr Ann Hoskins Director Children, Young People & Families Health and Wellbeing Content Overview of new PH system PHE function and structure Challenges

More information

Jerzy Mellibruda POLAND AT THE CROSSROADS OF EUROPE in search of better solutions for alcohol problems

Jerzy Mellibruda POLAND AT THE CROSSROADS OF EUROPE in search of better solutions for alcohol problems Jerzy Mellibruda POLAND AT THE CROSSROADS OF EUROPE in search of better solutions for alcohol problems 1. Shortly on a history of polish sobriety directed actions Poland has a long history of well-organized

More information

ORGANIZATION OF AMERICAN STATES

ORGANIZATION OF AMERICAN STATES ORGANIZATION OF AMERICAN STATES INTER-AMERICAN DRUG ABUSE CONTROL COMMISSION FIRST INTER-REGIONAL FORUM OF EU-LAC CITIES: PUBLIC POLICIES IN DRUG TREATMENT April 2 5, 2008 Santo Domingo, Dominican Republic

More information

The Global Economic Crisis and HIV Prevention and Treatment Programmes: Vulnerabilities and Impact. Executive Summary MEXICO

The Global Economic Crisis and HIV Prevention and Treatment Programmes: Vulnerabilities and Impact. Executive Summary MEXICO The Global Economic Crisis and HIV Prevention and Treatment Programmes: Vulnerabilities and Impact Executive Summary MEXICO October 2009 ACKOWLEDGEMENT The executive summary The Global Economic Crisis

More information

Kuwait. Medicine prices, availability, affordability and price components. Medicine prices matter

Kuwait. Medicine prices, availability, affordability and price components. Medicine prices matter prices, availability, affordability and price components prices matter Rapidly rising costs of health care and high medicine prices are a growing concern worldwide, especially in developing and transitional

More information

Results from the NPSinEurope.eu Project 5-Country RAR of New Psychoactive Drugs (NPS)

Results from the NPSinEurope.eu Project 5-Country RAR of New Psychoactive Drugs (NPS) Results from the NPSinEurope.eu Project 5-Country RAR of New Psychoactive Drugs (NPS) Grund, Jean-Paul Vavrinčíková, Lenka Janíková, Barbara Fidesová, Hana Health responses to NPS EMCDDA, Lisboa. 28-10-2015

More information

Service Coordinator British Red Cross and Macmillan Support at Home Service

Service Coordinator British Red Cross and Macmillan Support at Home Service Service Coordinator British Red Cross and Macmillan Support at Home Service Job Profile Salary band 2b Reference Area / Department Health & Social Care Territory / Division Northern. Area 2.3 Flexible

More information

Ending HIV/AIDS Among Injection Drug Users in Minnesota

Ending HIV/AIDS Among Injection Drug Users in Minnesota Ending HIV/AIDS Among Injection Drug Users in Minnesota SUMMARY OF COMMUNITY STAKEHOLDER INPUT July 2018 Prepared by Wilder Research Ending HIV/AIDS Among Injection Drug Users in Minnesota Minnesota Department

More information

More honoured in the breach

More honoured in the breach More honoured in the breach.. Bob Lewin CAREARE AND EDUCATION RESEARCH GROUPROUP Cardiac rehabilitation around the world (apart from Austria) is in a mess Austria 1997 90% Holland 60% UK 40% (of angio,,

More information

SESSION 3B: IMPROVING NUTRITION THROUGH SOCIAL PROTECTION PROGRAMS

SESSION 3B: IMPROVING NUTRITION THROUGH SOCIAL PROTECTION PROGRAMS SESSION 3B: IMPROVING NUTRITION THROUGH SOCIAL PROTECTION PROGRAMS Harold Alderman Senior Research Fellow Poverty, Health, and Nutrition IFPRI Keynote Presentation Moscow, September 10 Why Focus on Nutrition

More information

NATIONAL INSTITUTE FOR HEALTH AND CLINICAL EXCELLENCE SCOPE. Type 2 diabetes: the management of type 2 diabetes (update)

NATIONAL INSTITUTE FOR HEALTH AND CLINICAL EXCELLENCE SCOPE. Type 2 diabetes: the management of type 2 diabetes (update) NATIONAL INSTITUTE FOR HEALTH AND CLINICAL EXCELLENCE 1 Guideline title SCOPE Type 2 diabetes: the management of type 2 diabetes (update) 1.1 Short title Type 2 diabetes (update) 2 Background a) The National

More information

Putting NICE guidance into practice. Resource impact report: Hearing loss in adults: assessment and management (NG98)

Putting NICE guidance into practice. Resource impact report: Hearing loss in adults: assessment and management (NG98) Putting NICE guidance into practice Resource impact report: Hearing loss in adults: assessment and management (NG98) Published: June 2018 Summary This report focuses on the recommendation from NICE s guideline

More information

Authors: Jennifer Kates (Kaiser Family Foundation), José-Antonio Izazola (UNAIDS), Eric Lief (CSIS).

Authors: Jennifer Kates (Kaiser Family Foundation), José-Antonio Izazola (UNAIDS), Eric Lief (CSIS). Financing the response to AIDS in low- and middleincome countries: International assistance from the G8, European Commission and other donor Governments, 2006 Authors: Jennifer Kates (Kaiser Family Foundation),

More information

INTRODUCING THE PROGESTERONE CONTRACEPTIVE VAGINAL RING IN SUB-SAHARAN AFRICA

INTRODUCING THE PROGESTERONE CONTRACEPTIVE VAGINAL RING IN SUB-SAHARAN AFRICA SEPTEMBER 2016 project brief INTRODUCING THE PROGESTERONE CONTRACEPTIVE VAGINAL RING IN SUB-SAHARAN AFRICA Research supports the introduction of the Progesterone Vaginal Ring (PVR), a user-controlled method

More information

Improving global access to integrated ESKD care. David Harris 01/10/17

Improving global access to integrated ESKD care. David Harris 01/10/17 University of Sydney Westmead Hospital Improving global access to integrated ESKD care David Harris 01/10/17 the problem resources numbers GLOBAL 125/202 countries 6.73/7.24b (93%) ASIA 25/42 countries

More information

Dr. Mean Chhi Vun NCHADS Director

Dr. Mean Chhi Vun NCHADS Director Dr. Mean Chhi Vun NCHADS Director mchhivun@nchads.org The Second Phnom Penh Symposium on HIV Prevention, Care and Treatment Phnom Penh Hotel, Phnom Penh, Cambodia 15-16, December 2008 Outline Background

More information

COUNTRY STATEMENT (MALAYSIA)

COUNTRY STATEMENT (MALAYSIA) COUNTRY STATEMENT (MALAYSIA) By The Hon. Datuk Hajah Azizah binti Datuk Seri Panglima Mohd. Dun, Deputy Minister, Women, Family and Community Development, Malaysia 19 20 September 2013 Sixth Asian and

More information

Brain research supported by the European Union

Brain research supported by the European Union Brain research supported by the European Union Lara Passante, PhD Health Directorate Directorate-General for Research & European Commission FENS Featured Regional Meeting 11-14 Septembre 2013 Prague Neuroscience:

More information

Health and well-being a perspective from WHO

Health and well-being a perspective from WHO Meeting of Chief Medical Officers and Chief Nursing Officers Health and well-being a perspective from WHO Zsuzsanna Jakab WHO Regional Director for Europe Health 2020 European policy framework Health 2020

More information

2 nd Meeting on detecting and responding to outbreaks of HIV among PWID

2 nd Meeting on detecting and responding to outbreaks of HIV among PWID 2 nd Meeting on detecting and responding to outbreaks of HIV among PWID Update on country situation: ROMANIA Adrian Abagiu* & Andrei Botescu** *Romanian Association Against AIDS (ARAS) and National Institute

More information

Responsibility in the Age of Autonomous Machines

Responsibility in the Age of Autonomous Machines Responsibility in the Age of Autonomous Machines IEEE ARSO 2016 July 8, 2016 Shanghai Minao Kukita Graduate School of Information Science Nagoya University A fatal car accident by Tesla Model S while the

More information

The NHS contribution to public health the PHE perspective. Professor John Newton

The NHS contribution to public health the PHE perspective. Professor John Newton The NHS contribution to public health the PHE perspective Professor John Newton The challenges facing the NHS? Then Aging population Increasing patient expectations Advances in medical technology Now Aging

More information

HEALTH SECTOR AND ENVIRONMENTAL HEALTH IN KOSOVO Challenges & potentials

HEALTH SECTOR AND ENVIRONMENTAL HEALTH IN KOSOVO Challenges & potentials HEALTH SECTOR AND ENVIRONMENTAL HEALTH IN KOSOVO Challenges & potentials Ilirjana Bajraktari, MD, PhD Healthcare Professionals for Peace and Social Responsibility Content Introduction Country Health profile

More information

DEMAND FOR PRIVATE FERTILITY TREATMENTS IN UK MORE THAN DOUBLES IN ONE YEAR

DEMAND FOR PRIVATE FERTILITY TREATMENTS IN UK MORE THAN DOUBLES IN ONE YEAR DEMAND FOR PRIVATE FERTILITY TREATMENTS IN UK MORE THAN DOUBLES IN ONE YEAR UK enquires into private fertility treatments have more than doubled (up 112%) in the past 12 months Egg freezing has seen the

More information